Cargando…

Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections

This study was designed to investigate the role of serum GP73 for diagnosing significant fibrosis in patients with chronic hepatitis B virus (HBV) infections. Two populations were enrollment. All subjects were patients with chronic HBV infections. First population included 761 patients, who received...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Hongshan, Li, Boan, Zhang, Renwen, Hao, Xiaohua, Huang, Yubo, Qiao, Yong, Hou, Jun, Li, Xin, Li, Xingwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572132/ https://www.ncbi.nlm.nih.gov/pubmed/23418424 http://dx.doi.org/10.1371/journal.pone.0053862

Ejemplares similares

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015)

Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT
por: Wei, Meijuan, et al.
Publicado: (2019)

Research progress on GP73 in malignant tumors
por: Liang, Rong, et al.
Publicado: (2018)

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma
por: HOU, SI-CONG, et al.
Publicado: (2013)

GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
por: Liu, Yujuan, et al.
Publicado: (2021)

Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
por: Ke, Meng-yun, et al.
Publicado: (2019)

Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022)

Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients
por: Liao, Hao, et al.
Publicado: (2022)

Magnetic Resonance Imaging and Serum AFP-L3 and GP-73 in the Diagnosis of Primary Liver Cancer
por: Yuan, Jun-Jian, et al.
Publicado: (2022)

GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction
por: Yang, Xiaoli, et al.
Publicado: (2017)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
por: Yu, Wei-Ming, et al.
Publicado: (2023)

GP73 is down-regulated in gastric cancer and associated with tumor differentiation
por: Chen, Le-Gao, et al.
Publicado: (2013)

Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis
por: Li, Yadi, et al.
Publicado: (2021)

Screening and Identification of ssDNA Aptamer for Human GP73
por: Du, Jingchun, et al.
Publicado: (2015)

Expression and correlation of CD44 and GP73 in cerebroma tissues
por: Yuan, Yuan, et al.
Publicado: (2018)

Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC)
por: Bao, Yong xing, et al.
Publicado: (2013)

GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells
por: Ye, Jia-Zhou, et al.
Publicado: (2018)

c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment
por: Liu, Yiming, et al.
Publicado: (2019)

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
por: Liu, Tianhui, et al.
Publicado: (2017)

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

The Golgi Localization of GOLPH2 (GP73/GOLM1) Is Determined by the Transmembrane and Cytoplamic Sequences
por: Hu, Longbo, et al.
Publicado: (2011)

GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness
por: Jiang, Kai, et al.
Publicado: (2016)

Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA
por: Zhang, Aixia, et al.
Publicado: (2012)

GP73, a novel Golgi-localized protein upregulated by viral infection
por: Kladney, Raleigh D., et al.
Publicado: (2000)

Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure
por: Qu, Feng, et al.
Publicado: (2014)

Analysis of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA and Serum Viral Markers in Treatment-Naive Patients with Acute and Chronic HBV Infection
por: Li, Weijie, et al.
Publicado: (2014)

Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of α-fetoprotein, α-fetoprotein-L3, des-γ-carboxy prothrombin, and Golgi protein 73
por: Li, Bo, et al.
Publicado: (2017)

GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion
por: Hu, Longbo, et al.
Publicado: (2014)

Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver Cancer
por: Yu, Chuanwen, et al.
Publicado: (2022)

Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease
por: Liu, Langli, et al.
Publicado: (2018)

Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis
por: Sai, Wenli, et al.
Publicado: (2015)

The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma
por: Li, Bo, et al.
Publicado: (2017)

Application of serum Golgi protein-73 in the management of chronic liver disease
por: Yao, Ming-Jie, et al.
Publicado: (2021)

Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells
por: Wang, Fang, et al.
Publicado: (2014)

A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma
por: Pang, Bing-yao, et al.
Publicado: (2022)

The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment
por: Sun, Pengcheng, et al.
Publicado: (2022)

Research Progress on the Mechanism of Persistent Low-Level HBsAg Expression in the Serum of Patients with Chronic HBV Infection
por: Wu, Jie, et al.
Publicado: (2022)

Xenopus as a Model System for the Study of GOLPH2/GP73 Function: Xenopus golph2 Is Required for Pronephros Development
por: Li, Leike, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l2ddu60uu8rc2atuc89c4h9ikl